RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 39.95
+2.50 (6.68%)
May 13, 2025, 2:45 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 24.27 billion as of May 12, 2025. Its market cap has decreased by -5.34% in one year.
Market Cap
24.27B
Enterprise Value
26.42B
Revenue
2.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
39.95
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has decreased from 33.39B to 24.27B, a decrease of -27.31%. That is a compound annual growth rate of -6.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 24.27B | 73.32% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 194.78B |
| Hansoh Pharmaceutical Group Company | 140.92B |
| JD Health International | 121.51B |
| WuXi Biologics | 93.82B |
| Innovent Biologics | 81.49B |
| Alibaba Health Information Technology | 80.09B |
| Akeso | 75.71B |
| Sichuan Kelun-Biotech Biopharmaceutical | 71.46B |